E-viri
Recenzirano
Odprti dostop
-
Jakubowicz, Elżbieta; Martin, Benedikt; Hoffmann, Reinhard; Kröncke, Thomas; Jung, Thomas; Steierl, Roman; Steinfeld, Dieter; Schenkirsch, Gerhard; Kriegsmann, Jörg; Märkl, Bruno
The breast journal, May/June 2019, 2019-05-00, 20190501, Letnik: 25, Številka: 3Journal Article
We retrospectively investigated concordance of EndoPredict (EPclin) with urokinase plasminogen activator and plasminogen activator inhibitor‐1 (uPA/PAI‐1) in 72 breast cancer patients and compared the results with grading, molecular subtype and chemotherapy recommendation. Compared to uPA/PAI‐1, EPclin proved to be more conservative concerning correlation with clinicopathological parameters and was significantly associated with the recommendation of adjuvant chemotherapy.
